Skip to main content
Clinical Trials/NCT01824355
NCT01824355
Completed
Not Applicable

Performance of the Ninja 3 Plus Blood Glucose Monitoring System

Ascensia Diabetes Care1 site in 1 country113 target enrollmentMarch 2013
ConditionsDiabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes
Sponsor
Ascensia Diabetes Care
Enrollment
113
Locations
1
Primary Endpoint
Percent of Self Test Fingerstick Blood Glucose Results Within ±15 mg/dL (< 75 mg/dL) and Within ±20% (≥ 75 mg/dL) of the Laboratory Glucose Method
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study was to demonstrate that untrained subjects who have diabetes can operate the Investigational Blood Glucose Monitoring System (BGMS) and obtain valid glucose results.

Registry
clinicaltrials.gov
Start Date
March 2013
End Date
March 2013
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Ascensia Diabetes Care
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Males and females, 18 years of age or older.
  • People with type 1 or type 2 diabetes.
  • Able to speak, read and understand English.
  • Willing to complete all study procedures.

Exclusion Criteria

  • Hemophilia or any other bleeding disorder.
  • Physical, visual or neurological impairments that would make the person unable to perform testing with the BGM.
  • Previously participated in a blood glucose monitoring study using the Ninja 3 Plus BGMS.
  • Working for a medical laboratory, hospital or other clinical setting that involves training on or clinical use of blood glucose meters.
  • Working for a competitive medical device company, or having an immediate family member who works for such a company.
  • A condition, which in the opinion of the investigator or designee, would put the person or study conduct at risk.

Outcomes

Primary Outcomes

Percent of Self Test Fingerstick Blood Glucose Results Within ±15 mg/dL (< 75 mg/dL) and Within ±20% (≥ 75 mg/dL) of the Laboratory Glucose Method

Time Frame: 1 hour

Untrained subjects with diabetes who self-tested fingerstick blood used the Ninja 3 PLUS investigational Blood Glucose Monitoring System (BGMS). BGMS results were compared with capillary plasma BG results obtained with a reference laboratory glucose method - YSI Life Sciences (YSI) Analyzer. BG meter results were used to calculate the number of BGMS results within +/- 15mg/dL (for reference BG results \<75mg/dL) and within +/- 20% (for reference BG results \>=75mg/dL) of the YSI reference method results.

Secondary Outcomes

  • Percent of Fingerstick Blood Glucose Results Within ±15 mg/dL (< 75 mg/dL) and Within ±20% (≥ 75 mg/dL) of the Laboratory Glucose Method When Tested by Study Staff(one hour)
  • Number of Subject Responses That 'Strongly Agree' or 'Agree' or Are 'Neutral' With Questionnaire Statements(1 hour)
  • Percent of Self Test Fingerstick Blood Glucose Results Within ±15 mg/dL (< 100 mg/dL) and Within ±15% (≥ 100 mg/dL) of the Laboratory Glucose Method(1 hour)
  • Percent of Self Test Fingerstick Blood Glucose Results Within ±12.5 mg/dL (< 100 mg/dL) and Within ±12.5% (≥ 100 mg/dL) of the Laboratory Glucose Method(1 hour)
  • Percent of Blood Glucose Results From Alternative Site Testing (AST) of the Palm Within ±15 mg/dL (< 75 mg/dL) and Within ±20% (≥ 75 mg/dL) of the Laboratory Method.(1 hour)

Study Sites (1)

Loading locations...

Similar Trials